483
Abbvie Biotechnology Ltd.FDA 483 - Abbvie Biotechnology Ltd.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Abbvie Biotechnology LTD in Barceloneta, Puerto Rico, revealed significant deficiencies in quality control systems. The firm failed to adequately investigate and document consumer complaints for its Humira product, and laboratory investigations lacked sufficient supporting evidence. Additionally, procedures for inspecting raw materials and syringes were found to be inadequate, potentially impacting product quality.
- Company
- Abbvie Biotechnology Ltd.
- Product Type
- Drugs
Open in Dashboard
ID · b841e8d1-f95e-4ef1-bf9f-48c8f728cd44